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Abstract Since 1991, the skin bank of the Queen
Astrid Military Hospitalusesfood-gradealuminumfoil
as a primary support for storing cryo preserved human
donor skin (511 donors). The possible release of heavy
metals into the cryo preservation media (30% (v/v)
glycerolinphysiologicalwater)andthepossibleimpact
this release could have on the quality of the cryo
preserveddonorskinwasevaluated.Aluminumwasthe
principal detection target. Possible contaminants of the
aluminum foil as such (arsenic, cadmium, chromium
andlead)werealsoinvestigated.Theevaluationwasset
up after a Belgian Competent Authority inspection
remark. Aluminum was detected at a concentration of
1.4 mg/l, arsenic and lead were not detected, while
cadmium and chromiumweredetectedintrace element
quantities. An histological analysis revealed no differ-
ences between cryo preserved and fresh donor skin. No
adverse reactions in patients, related to the presence of
aluminum or heavy metal traces, were reported since
the introduction of the cryo preserved donor skin in our
burn wound centre.
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Introduction and rationale
Theintertwinedqualityandsafetyissuesareessentialin
all medical activities. Also in the fast growing ﬁeld of
tissue and cell banking there is an increased awareness.
The skin bank of the Queen Astrid Military Hospital
uses food-grade aluminum foil (Alcomet, Aluminum
foil 8011A) as a primary support for storing cryo
preservedhumandonorskin.Thisprocedureisinusein
our skin bank since 1991. We process about 65 skin
donors each year. This quantity covers the need of the
Brussels burn wound centre. The storage time in our
skin bank ranges in practice from 1 month to 1 year.
Since the beginning of our activities, cryo donor skin
retain samples were taken and stored for future use in
safety and quality related tests.
Tissue banking is a ﬁeld in which an intensive
and worldwide growth and exchange is emerging.
G. Verbeken (&)  D. Schoeters  G. Verween 
D. De Vos  B. Pascual  P. De Corte 
T. Rose  J.-P. Pirnay
LabMCT, Skin- and Keratinocyte Bank, Burn Wound
Centre, Queen Astrid Military Hospital, Brussels,
Belgium
e-mail: gilbert.verbeken@mil.be
K. Geukens
Department for Chemical Analysis, CBRN—Laboratories
of the Belgian Ministry of Defense, Peutie, Belgium
A. De Coninck  D. Roseeuw
Department of Dermatology and Pathology, UZ Brussel,
Vrije Universiteit Brussel, Brussels, Belgium
S. Jennes
Burn Wound Centre, Queen Astrid Military Hospital,
Brussels, Belgium
123
Cell Tissue Bank (2011) 12:241–246
DOI 10.1007/s10561-010-9171-yIn order to safeguard quality and safety, controlled
and validated standard operating procedures are
needed. A recent inspection by the Belgian Compe-
tent Authority raised the question whether ‘food-
grade’ aluminum foil is suitable for use in our donor
skin cryo preservation procedure. To be more
speciﬁc, we were asked whether the possible release
of aluminum and/or heavy metal contaminants from
the food-grade aluminum foil into the cryo preserva-
tion medium could have a negative impact on the
quality of the cryo preserved donor skin and subse-
quently on the recipient patient.
With this short communication we try to answer
this pertinent question in a pragmatic way.
Aluminum was the principal targeted analyte, but
some relevant heavy metal contaminants like arsenic
(As), cadmium (Cd), chromium (Cr) and lead (Pb)
were also taken into account, because they are known
to be present, in trace element quantities, in the
considered aluminum foils.
To investigate this issue we proceeded as follows.
First, a quantitative analysis of the above mentioned
metals in skin cryo preservation medium, retrieved
from stored retain samples, was performed. Second, a
histological analysis of the stored cryo preserved
donor skin was performed in comparison to fresh
human skin. Third, we questioned burn surgeons,
who had used our cryo preserved skin on their
patients since 1991, about any aluminum or heavy
metal related adverse (clinical) reactions.
Materials and methods
Donor skin packaging
Donor skin (Fig. 1) is impregnated, for 30 min, in
cryo preservation medium (30% (v/v) glycerol in
physiological water) and transferred to a food-grade
aluminum foil support (Fig. 2). The donor skin is in
direct contact with the aluminum foil support.
Each aluminum foil support holds approximately
300 cm
2 of donor skin. After addition of an extra
5 ml of cryo preservation medium, each aluminum
foil support is folded and seal-packed in a Class IIa
laminated aluminum pouch (Fig. 3), which provides
for an extra mechanical protection during the long-
term storage of the skin grafts (Fig. 4) in the vapor
phase of liquid nitrogen (\-135C).
Quantitative detection of metal contaminants
Set up 1
Metal contaminants (Al, As, Cd, Cr, Pb) were
quantitatively measured in the individual cryo
Fig. 1 Fresh donor skin impregnation in cryo medium
Fig. 2 Donor skin on food-grade aluminum foil support
Fig. 3 Donor skin seal-packed in double pouch
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(10 donors), with storage times ranging from 20 h to
10 years, using graphite furnace atomic absorption
spectrometry (GFAAS).
Set up 2
Aluminum was quantitatively measured in the pooled
cryo preservation medium from seven donor skin
retain samples (7 donors), with a storage time of
10 years, using inductively coupled plasma atomic
emission spectrometry (ICP-AES).
Cryo preservation medium that had not been in
contact with food-grade aluminum foil and did not
have contact with cryo preserved donor skin either
was used as a control sample in both set ups.
Histological analysis
The retain skin samples from set up 1 (see section
above) were ﬁxated in formol at 10% and sent to the
pathological anatomy service for histological analy-
sis. Two stains were carried out; a classical haema-
toxylin eosin staining for the evaluation of the
general cellular structure followed by a periodic acid
Shiff reaction (PAS), which allows a thorough
evaluation of the skin basal membrane.
An experienced dermato-pathologist performed a
blind microscopic evaluation of the structural integ-
rity of the skin retain samples in comparison to fresh
skin samples. This evaluation was based on the
pigmentation, presence and integrity of hair follicles
and their associated muscles, sweat and sebaceous
glands, and the dermal-epidermal junction. The skin
samples were also screened for the presence of
apoptotic and/or necrotic cells, sentinels of local
tissue stress and inﬂammation.
Clinical evaluation
Burn surgeons (16), who had used our donor skin
during the past 15 years, were contacted and ques-
tioned by the actual Medical Director of the Skin
Bank about any aluminum or heavy metal related
adverse (clinical) reactions, using a standardized
questionnaire. Allergic reactions, intoxications, irri-
tations, other?
Results
Chemical analysis
The GFAAS measurements of Al, As, Cd, Cr, Pb in
the cryo preservation media of 10 donor skin retain
samples are shown in Table 1. Al, As and Pb were
not detected (below detection limit), while Cd and Cr
were detected in trace element quantities (ppm, mg/l).
The ICP-AES measurements of Al in the pooled
cryo preservation medium of seven donor skin retain
samples, all dating from 10 years old, are shown in
Table 2. Aluminum was detected at a concentration
of 1.4 mg/l.
Histological analysis
The histological analysis revealed no differences
between the cryo preserved donor skin retain samples
and fresh skin (Fig. 5).
Hair follicles and sweat and sebaceous glands
were clearly present and intact in the cryo preserved
skin. The cryo preserved skin harbored no apoptotic
or necrotic cells and showed a normal pigmentation
and an intact dermal-epidermal junction.
Fig. 4 Donor skin stored in vapor phase of liquid nitrogen
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10 years) had no impact on the results.
Clinical evaluation
No adverse reactions (e.g. hypersensitive reactions or
signs of intoxication) related to the presence of
aluminum or heavy metal traces in the grafts were
reported.
Discussion
According to the European Medical Device Directive
(MEDDEV), packaging materials for human cells
Table 1 Aluminum and other metal concentrations in skin cryo preservation medium retain samples
Donor ref. Contact time Aluminum (Al) Arsenic (As) Cadmium (Cd) Chromium (Cr) Lead (Pb)
GFAAS technology (mg/l)
BSB-08 067 21.5 h bdl
a bdl bdl bdl bdl
BSB-08 068 3 Days bdl bdl bdl 0.0016 bdl
BSB-08 053 15 Weeks bdl bdl bdl 0.0111 bdl
BSB-08 056 14 Weeks bdl bdl bdl 0.0029 bdl
BSB-08 062 10 Weeks bdl bdl bdl bdl bdl
BSB-98 001 10 Years bdl bdl bdl 0.0242 bdl
BSB-98 003 10 Years bdl bdl 0.0045 0.0218 bdl
BSB-98 004 10 Years bdl bdl 0.001 0.0085 bdl
BSB-98 007 10 Years bdl bdl 0.003 0.018 bdl
BSB-98 008 10 Years bdl bdl 0.0045 0.0108 bdl
BLANC BLANC bdl bdl bdl 0.0042 bdl
Detection limits ppm (mg/l)
Aluminum 0.040–2000
Arsenic 3–150
Cadmium 0.02–3
Chromium 0.06–15
Lead 0.10–30
a bdl below detection limit
Table 2 Aluminum concentration of the seven pooled skin
cryo preservation medium retain samples
Donor ref. Contact time Aluminum (Al)
ICP-AES technology (mg/l)
BSB-99 001 10 Years 1.4
BSB-99 003 10 Years
BSB-99 004 10 Years
BSB-99 005 10 Years
BSB-99 006 10 Years
BSB-99 007 10 Years
BSB-99 010 10 Years
BLANC BLANC bdl
a
Detection limit Al: 100 ll/l
a bdl below detection limit
Fig. 5 Donor skin section (2009, haematoxylin eosin staining
and PAS reaction) after 10 years cryo storage
244 Cell Tissue Bank (2011) 12:241–246
123and tissues for human application should be certiﬁed
Class IIa Medical Devices. Speciﬁc human cells and
tissues need speciﬁc (tailor made) packaging mate-
rials. For some speciﬁc applications, like the cryo
preservation of skin, suitable Class IIa packaging
materials are not available on the market.
Inthosecasesregulatorybodiesshouldaccepttheuse
ofnon-ClassIIa (e.g.food-grade) products,pendingthe
eventual development and commercialization of ade-
quate Class IIa materials. A proper validation of the
adequacyofthesenon-ClassIIamaterialsinthespeciﬁc
application is, however, warranted.
The cryo preservation solution is removed by an
obligatory procedural rinsing step before clinical use
and is therefore only indicative for the level of
absorption of aluminum and/or heavy metals in the
tissue, which is in turn only indicative for the
adsorptions of these contaminants in the recipient
patient. The ﬁnal absorption levels of aluminum foil
related contaminants in the patients is bound to be
procedure and tissue dependent.
The timely and quantitative analysis of serum or
plasma aluminum and heavy metal levels in the
recipients of grafts that were in contact with alumi-
num foil could once and for all resolve this issue.
Aluminum serum/plasma levels are indicative for
recent high aluminum exposure or uptake by a person
or an animal (Kausz et al. 1999; Ghori and Yaqub
1999; Klein et al. 1993; Tietz 1926).
The aluminum and heavy metal levels in the skin
cryo preservation solution, however, are very low
(below the detection limit or trace element quanti-
ties), even after an unusually long contact time
(10 years), and therefore suggest that the contaminant
levels in the recipient patient are probably negligible.
In the past, sterilized food-grade aluminum foil was
oftenusedasaprimarywounddressing.Aluminumfoil
therapy was introduced by Steinhardt in 1924 and since
then it was mostly used in burns but also in ulcers. The
advantages of aluminum foil dressings, which were
historicallydescribedare:readilyavailable(Johns1949;
Hambury1957),easytosterilize(Johns1949;Hambury
1957),non-toxic(Johns1949;Ha mb ur y1957),absence
ofsensitivityreactions(Hambury1957),non-expensive
(Johns 1949; Hambury 1957), easy to apply (Johns
1949), prevents crust formation (McAvoy et al. 1979),
bacteriostatic (Haeger 1963), non-adherent to sutures
(Southwood 1951;M c A v o ye ta l .1979)a n dc o m f o r t -
able for the patients (Johns 1949;S o u t h w o o d1951;
McAvoy et al. 1979). In 2005, Muneuchi etal. success-
fully treated gangrene as a result of malignant rheuma-
toid arthritis with aluminum foil combined with bFGF
(Muneuchi et al. 2005). In the seventies, Poole and
colleagues measured no signiﬁcant upsurge in serum or
plasma aluminum levels in patients in whom sterilized
food-grade aluminum foil was used as a temporary
wound dressing (Poole et al. 1979).
In addition we would like to stress that aluminum
is the most abundant metallic element on Earth and
this since the origin of life. No aluminum-speciﬁc
biological function has been reported, neither were
signiﬁcant intoxications, with the exception of some
Chronic Renal Failure situations (D’Haese et al.
1999). A recent study showed that there is no
association between the aluminum content of bone
and mortality risk (Hellstrom et al. 2008).
While aluminum has been described as a potential
trigger of apoptosis (Ganrot 1986; Franchini et al.
2009), an histological evaluation did not reveal any
sign of this process in our cryo preserved skin tissue.
Conclusion
The small amounts of aluminum and heavy metals
that leached into the cryo preservation medium had
no effect on the quality of the cryo preserved donor
skin allograft. A retrospective analysis revealed no
relevant adverse effects in the recipient patients. A
thorough rinsing of cryo preserved donor skin
allograft before clinical use remains a mandatory
procedural step, even if only to remove the often
toxic cryo protectant. Further studies could focus on
the determination of aluminum and heavy metal
concentrations in human tissue grafts that came into
contact with aluminium foil and/or the subsequent
plasma/serum levels in the recipient patients.
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